Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Efficacy, cosmesis and skin toxicity in a hypofractionated irradiation schedule for cutaneous basal cell carcinoma of the head and neck area.

Guida A, Kouloulias V, Kouvaris J, Mosa E, Georgakopoulos J, Platoni K, Papadopoulos O, Papadavid E, Zygogianni A, Rigoppoulos D, Antypas C, Beli I, Karantonis F, Kelekis N.

Head Neck Oncol. 2012 Dec 21;4:88.

PMID:
23296287
[PubMed]
2.

A new hypofractionated schedule of weekly irradiation for basal cell carcinoma of the head and neck skin area in elderly patients.

Kouloulias V, Papadavid E, Mosa E, Platoni K, Papadopoulos O, Rigopoulos D, Georgakopoulos J, Beli I, Karantonis F, Castana O, Dalamaga M, Kelekis N.

Dermatol Ther. 2014 May-Jun;27(3):127-30.

PMID:
24571239
[PubMed - in process]
3.

Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.

Corvò R, Giudici S, Maggio F, Bevegni M, Sampietro C, Lucido MR, Orsatti M.

Tumori. 2008 Sep-Oct;94(5):706-11.

PMID:
19112945
[PubMed - indexed for MEDLINE]
4.

Evaluation of acute/late toxicity and local recurrence in T1-T2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT).

Kouloulias VE, Zygogianni A, Mosa E, Platoni K, Georgakopoulos J, Antypas C, Beli I, Tolia M, Maragoudakis P, Giotakis I, Papas Z, Psyrri A, Kelekis N, Kouvaris J.

Radiol Oncol. 2013 May 21;47(2):185-91. doi: 10.2478/raon-2013-0020. Print 2013 Jun.

PMID:
23801916
[PubMed]
Free PMC Article
5.

Impact of acute radiation induced toxicity of glutamine administration in several hypofractionated irradiation schedules for head and neck carcinoma.

Zygogianni A, Kyrgias G, Kouvaris J, Pistevou-Gombaki K, Capezzali G, Zefkili S, Kokkakis J, Georgakopoulos J, Kelekis N, Kouloulias V.

Head Neck Oncol. 2012 Dec 14;4:86.

PMID:
23296285
[PubMed]
6.

Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.

Lambrecht M, Nevens D, Nuyts S.

Strahlenther Onkol. 2013 Mar;189(3):223-9. doi: 10.1007/s00066-012-0289-7. Epub 2013 Jan 16.

PMID:
23319256
[PubMed - indexed for MEDLINE]
7.

Accelerated Hypofractionated Whole-Breast Irradiation With Concomitant Daily Boost in Early Breast Cancer.

Kyrgias G, Zygogianni A, Theodorou K, Koukourakis M, Oikonomou A, Kouvaris J, Kouloulias V.

Am J Clin Oncol. 2013 Aug 7. [Epub ahead of print]

PMID:
23934132
[PubMed - as supplied by publisher]
8.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
[PubMed - indexed for MEDLINE]
9.

Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.

Cante D, Rosa La Porta M, Casanova-Borca V, Sciacero P, Girelli G, Pasquino M, Franco P, Ozzello F.

Breast J. 2011 Nov-Dec;17(6):586-93. doi: 10.1111/j.1524-4741.2011.01159.x. Epub 2011 Sep 21.

PMID:
21951485
[PubMed - indexed for MEDLINE]
10.

A weekly hypofractionated radiotherapeutic schedule for bladder carcinoma in elderly patients: local response, acute and late toxicity, dosimetric parameters and pain relief.

Zygogianni A, Kouloulias V, Armpilia C, Antypas C, Kantzou I, Balafouta M, Kyrgias G, Sarris G, Kelekis N, Kouvaris J.

J BUON. 2013 Apr-Jun;18(2):407-12.

PMID:
23818353
[PubMed - indexed for MEDLINE]
11.

[Radiotherapy of basal cell carcinoma of the face and head: Importance of low dose per fraction on long-term outcome].

Olschewski T, Bajor K, Lang B, Lang E, Seegenschmiedt MH.

J Dtsch Dermatol Ges. 2006 Feb;4(2):124-30. Review. German.

PMID:
16503939
[PubMed - indexed for MEDLINE]
12.

Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.

Scorsetti M, Alongi F, Fogliata A, Pentimalli S, Navarria P, Lobefalo F, Garcia-Etienne C, Clivio A, Cozzi L, Mancosu P, Nicolini G, Vanetti E, Eboli M, Rossetti C, Rubino A, Sagona A, Arcangeli S, Gatzemeier W, Masci G, Torrisi R, Testori A, Alloisio M, Santoro A, Tinterri C.

Radiat Oncol. 2012 Aug 28;7:145. doi: 10.1186/1748-717X-7-145.

PMID:
22929062
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.

Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.

Am J Clin Oncol. 2009 Jun;32(3):314-8. doi: 10.1097/COC.0b013e31818af0b9.

PMID:
19451803
[PubMed - indexed for MEDLINE]
14.

Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.

Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):489-95. Epub 2005 Oct 24.

PMID:
16246495
[PubMed - indexed for MEDLINE]
15.

Evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer.

Kouloulias V, Tolia M, Kolliarakis N, Siatelis A, Kelekis N.

Int Braz J Urol. 2013 Jan-Feb;39(1):77-82. doi: 10.1590/S1677-5538.IBJU.2013.01.10.

PMID:
23489500
[PubMed - indexed for MEDLINE]
Free Article
16.

The impact of intermediate time between chemotherapy and hypofractionated radiotherapy to the radiation induced skin toxicity for breast adjuvant treatment.

Zygogianni A, Kouloulias V, Antypas C, Armpilia C, Kyrgias G, Kouvaris J.

Breast J. 2014 Jan-Feb;20(1):74-8. doi: 10.1111/tbj.12206. Epub 2013 Nov 18.

PMID:
24237451
[PubMed - in process]
17.

Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.

Butler EB, Teh BS, Grant WH 3rd, Uhl BM, Kuppersmith RB, Chiu JK, Donovan DT, Woo SY.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):21-32.

PMID:
10477002
[PubMed - indexed for MEDLINE]
18.

Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.

Al-mamgani A, Tans L, Van rooij PH, Noever I, Baatenburg de jong RJ, Levendag PC.

Acta Oncol. 2009;48(4):562-70. doi: 10.1080/02841860902740899.

PMID:
19373698
[PubMed - indexed for MEDLINE]
19.

A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.

Guenzi M, Vagge S, Azinwi NC, D'Alonzo A, Belgioia L, Garelli S, Gusinu M, Corvò R.

Radiat Oncol. 2010 Nov 22;5:111. doi: 10.1186/1748-717X-5-111.

PMID:
21092219
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.

Jegannathen A, Mais K, Sykes A, Lee L, Yap B, Birzgalis A, Homer J, Ryder WD, Slevin N.

Clin Oncol (R Coll Radiol). 2011 Mar;23(2):149-58. doi: 10.1016/j.clon.2010.09.010. Epub 2010 Oct 14.

PMID:
20951012
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk